Skip to Content
Merck

Key Documents

View All Documentation

Skip To

HPA036104

Sigma-Aldrich

Anti-COL18A1 antibody produced in rabbit

Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody

Synonym(s):

KNO, KNO1, KS

Sign Into View Organizational & Contract Pricing

Select a Size

200 EA
RM 303.00

RM 303.00

Check Cart for Availability

Select a Size

Change View
200 EA
RM 303.00

About This Item

UNSPSC Code:
12352203
Human Protein Atlas Number:
HPA036104
NACRES:
NA.41

RM 303.00

Check Cart for Availability
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

rabbit

Quality Level

100

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

product line

Prestige Antibodies® Powered by Atlas Antibodies

form

buffered aqueous glycerol solution

species reactivity

human

technique(s)

immunofluorescence: 0.25-2 μg/mL

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
SYNA351420SYNA351024SYNA351424
Synthware™ distillation adapter top joint: ST/NS 10/18, immersion depth 50 mm, side arm angle: 75 deg

SYNA351014

Synthware™ distillation adapter

Synthware™ distillation adapter top joint: ST/NS 14/20, bottom joint: ST/NS 14/20, side joint: 14/20, side arm angle: 75 deg

SYNA351420

Synthware™ distillation adapter

Synthware™ distillation adapter top joint: ST/NS 10/18, bottom joint: ST/NS 24/40, side joint: 24/40, immersion depth 50 mm, side arm angle: 75 deg

SYNA351024

Synthware™ distillation adapter

Synthware™ distillation adapter top joint: ST/NS 14/20, bottom joint: ST/NS 24/40, side joint: 24/40, side arm angle: 75 deg

SYNA351424

Synthware™ distillation adapter

joint

joint: ST/NS top10/18

joint

bottom joint: ST/NS14/20, side joint: 14/20, joint: ST/NS top14/20

joint

bottom joint: ST/NS24/40, side joint: 24/40, joint: ST/NS top10/18

joint

bottom joint: ST/NS24/40, side joint: 24/40, joint: ST/NS top14/20

manufacturer/tradename

Synthware A351014

manufacturer/tradename

Synthware A351420

manufacturer/tradename

Synthware A351024

manufacturer/tradename

Synthware A351424

packaging

pkg of 1 ea

packaging

pkg of 1 ea

packaging

pkg of 1 ea

packaging

pkg of 1 ea

immersion depth

50 mm

immersion depth

-

immersion depth

50 mm

immersion depth

-

Immunogen

collagen, type XVIII, alpha 1

Application

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies® protocols and other useful information.

Features and Benefits

Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:
  • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
  • Protein array of 364 human recombinant protein fragments.

Linkage

Corresponding Antigen APREST90821

Physical form

Solution in phosphate buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    R33579

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Tomoko Soga et al.
    Neuropharmacology, 59(1-2), 77-85 (2010-04-13)
    Citalopram is the most potent selective serotonin reuptake inhibitor (SSRI) which is used as an antidepressant but causes sexual dysfunction. Whether citalopram induced sexual dysfunction is a result of gonadotropin-releasing hormone (GnRH), kisspeptin or RF-amide related peptide (RFRP) alteration is
    Interactions between whole-body heating and citalopram on body temperature, antidepressant-like behaviour, and neurochemistry in adolescent male rats
    Hale MW, et al.
    Behavioural Brain Research, 359, 428-439 (2019)
    Whole-body hyperthermia and a subthreshold dose of citalopram act synergistically to induce antidepressant-like behavioral responses in adolescent rats
    Hale MW, et al.
    Progress in Neuro-Psychopharmacology & Biological Psychiatry, 79, 162-168 (2017)
    Inhibition of the serotonin transporter is altered by metabolites of selective serotonin and norepinephrine reuptake inhibitors and represents a caution to acute or chronic treatment paradigms
    Krout D, et al.
    ACS Chemical Neuroscience, 8(5), 1011-1018 (2016)
    Current Treatments of Obsessive-Compulsive Disorder (2008)
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service